Schmidt-Wolf IG - Search Results

1

Enhanced inhibition of tumor growth with depletion of CD25 regulatory cells and intratumoral immunization with tumor RNA-pulsed dendritic cells in a C57BL/6 pancreatic tumor model.

Linke A, Brossart P, Schmidt-Wolf IG, Gonzalez-Carmona MA, Ziske C, Messmer D, Schmitz V, Sauerbruch T. Linke A, et al. Pancreas. 2009 Jul;38(5):602-4. doi: 10.1097/MPA.0b013e3181a11bde. Pancreas. 2009. PMID: 19550282 No abstract available.

2

Combinations of the cytokines IL-12, IL-2 and IFN-alpha significantly augment whereas the cytokine IL-4 suppresses the cytokine-induced antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2.

Flieger D, Spengler U, Beier I, Sauerbruch T, Schmidt-Wolf I. Flieger D, et al. Cytokine. 2000 Jun;12(6):756-61. doi: 10.1006/cyto.1999.0610. Cytokine. 2000. PMID: 10843759

3

Increase of the immunostimulatory effect of dendritic cells by pulsing with CA 19-9 protein.

Märten A, Schöttker B, Ziske C, Weineck S, Buttgereit P, Huhn D, Sauerbruch T, Schmidt-Wolf IG. Märten A, et al. J Immunother. 2000 Jul-Aug;23(4):464-72. doi: 10.1097/00002371-200007000-00010. J Immunother. 2000. PMID: 10916756

4

Increase in the immunostimulatory effect of dendritic cells by pulsing with serum derived from pancreatic and colorectal cancer patients.

Märten A, Ziske C, Schöttker B, Renoth S, Weineck S, Buttgereit P, Schakowski F, Klingmüller D, Scheffold C, von Rücker A, Sauerbruch T, Schmidt-Wolf IG. Märten A, et al. Int J Colorectal Dis. 2000 Aug;15(4):197-205. doi: 10.1007/s003840000243. Int J Colorectal Dis. 2000. PMID: 11008718

5

Resistance of pancreatic carcinoma cells is reversed by coculturing NK-like T cells with dendritic cells pulsed with tumor-derived RNA and CA 19-9.

Ziske C, Märten A, Schöttker B, Buttgereit P, Schakowski F, Gorschlüter M, von Rücker A, Scheffold C, Chao N, Sauerbruch T, Schmidt-Wolf IG. Ziske C, et al. Mol Ther. 2001 Jan;3(1):54-60. doi: 10.1006/mthe.2000.0230. Mol Ther. 2001. PMID: 11162311 Free article.

6

Littoral cell angioma as a rare cause of splenomegaly.

Ziske C, Meybehm M, Sauerbruch T, Schmidt-Wolf IG. Ziske C, et al. Ann Hematol. 2001 Jan;80(1):45-8. doi: 10.1007/s002770000223. Ann Hematol. 2001. PMID: 11233776

7

Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs.

Märten A, Ziske C, Schöttker B, Weineck S, Renoth S, Buttgereit P, Schakowski F, König S, von Rücker A, Allera A, Schroers R, Sauerbruch T, Wittig B, Schmidt-Wolf IG. Märten A, et al. Cancer Gene Ther. 2001 Mar;8(3):211-9. doi: 10.1038/sj.cgt.7700292. Cancer Gene Ther. 2001. PMID: 11332992

8

Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma.

Gorschlüter M, Ziske C, Glasmacher A, Schmidt-Wolf IG. Gorschlüter M, et al. Clin Cancer Res. 2001 Aug;7(8):2195-204. Clin Cancer Res. 2001. PMID: 11489792 Review.

9

Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells.

Märten A, Renoth S, von Lilienfeld-Toal M, Buttgereit P, Schakowski F, Glasmacher A, Sauerbruch T, Schmidt-Wolf IG. Märten A, et al. Haematologica. 2001 Oct;86(10):1029-37. Haematologica. 2001. PMID: 11602408

10

Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations.

Märten A, Ziske C, Schöttker B, Renoth S, Weineck S, Buttgereit P, Schakowski F, von Rücker A, Sauerbruch T, Schmidt-Wolf IG. Märten A, et al. J Immunother. 2001 Nov-Dec;24(6):502-10. doi: 10.1097/00002371-200111000-00007. J Immunother. 2001. PMID: 11759073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters